Jill Miller, PA-C

NPI: 1932370038
Total Payments
$17,496
2024 Payments
$5,492
Companies
17
Transactions
132
Medicare Patients
504
Medicare Billing
$23,508

Payment Breakdown by Category

Consulting$9,729 (55.6%)
Food & Beverage$5,236 (29.9%)
Travel$1,919 (11.0%)
Other$430.00 (2.5%)
Education$181.94 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $9,729 11 55.6%
Food and Beverage $5,236 110 29.9%
Travel and Lodging $1,919 8 11.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $430.00 1 2.5%
Education $181.94 2 1.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $6,177 26 $0 (2024)
Adaptive Biotechnologies Corporation $5,383 26 $0 (2024)
Pharmacyclics LLC, An AbbVie Company $2,429 13 $0 (2023)
Janssen Biotech, Inc. $717.37 11 $0 (2024)
TG THERAPEUTICS, INC. $630.00 1 $0 (2021)
Astellas Pharma US Inc $543.99 13 $0 (2024)
AstraZeneca Pharmaceuticals LP $506.54 12 $0 (2024)
BeiGene USA, Inc. $382.20 7 $0 (2024)
E.R. Squibb & Sons, L.L.C. $126.86 1 $0 (2023)
Genentech, Inc. $115.77 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,492 43 Adaptive Biotechnologies Corporation ($4,356)
2023 $4,124 36 ABBVIE INC. ($2,828)
2022 $3,795 36 Pharmacyclics LLC, an AbbVie Company ($2,253)
2021 $4,085 17 AbbVie Inc. ($2,837)

All Payment Transactions

132 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/17/2024 ABBVIE INC. VENCLEXTA (Drug) Food and Beverage In-kind items and services $25.27 General
Category: ONCOLOGY
12/04/2024 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug) Food and Beverage In-kind items and services $23.56 General
Category: Oncology
12/03/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $31.64 General
Category: Oncology
11/19/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $109.71 General
Category: ONCOLOGY
11/19/2024 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug) Food and Beverage In-kind items and services $30.88 General
Category: Oncology
11/15/2024 ABBVIE INC. VENCLEXTA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: ONCOLOGY
11/15/2024 BeiGene USA, Inc. BRUKINSA (Drug) Food and Beverage In-kind items and services $43.95 General
Category: Oncology
11/14/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $112.03 General
Category: Oncology
11/13/2024 Lilly USA, LLC JAYPIRCA (Drug) Food and Beverage In-kind items and services $21.36 General
Category: Oncology
10/17/2024 Astellas Pharma US Inc Cresemba (Drug) Food and Beverage In-kind items and services $31.39 General
Category: Infectious Diseases
10/08/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $29.50 General
Category: Oncology
10/08/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $8.31 General
Category: ONCOLOGY
09/26/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Consulting Fee Cash or cash equivalent $430.00 General
Category: ONCOLOGY
09/26/2024 Invivyd Inc PEMGARDA (Biological) Food and Beverage In-kind items and services $18.80 General
Category: INFECTIOUS DISEASE
09/25/2024 BeiGene USA, Inc. BRUKINSA (Drug) Food and Beverage In-kind items and services $31.33 General
Category: Oncology
09/25/2024 BeiGene USA, Inc. BRUKINSA (Drug) Food and Beverage In-kind items and services $2.00 General
Category: Oncology
09/17/2024 BeiGene USA, Inc. BRUKINSA (Drug) Food and Beverage In-kind items and services $148.45 General
Category: Oncology
09/17/2024 ABBVIE INC. VENCLEXTA (Drug) Food and Beverage In-kind items and services $27.41 General
Category: ONCOLOGY
09/05/2024 ABBVIE INC. VENCLEXTA (Drug) Food and Beverage In-kind items and services $100.92 General
Category: ONCOLOGY
08/20/2024 SOBI, INC VONJO (Drug) Food and Beverage In-kind items and services $26.28 General
Category: HEMATOLOGY/ONCOLOGY
08/07/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $76.92 General
Category: ONCOLOGY
08/06/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $28.91 General
Category: Oncology
08/01/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Consulting Fee Cash or cash equivalent $2,257.50 General
Category: ONCOLOGY
08/01/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Consulting Fee Cash or cash equivalent $913.75 General
Category: ONCOLOGY
07/26/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $2.50 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 168 204 $41,211 $7,648
2022 3 82 92 $15,482 $4,030
2021 4 140 162 $27,593 $7,642
2020 2 114 152 $20,386 $4,188
Total Patients
504
Total Services
610
Medicare Billing
$23,508
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 87 114 $19,476 $5,097 26.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Facility 2023 49 57 $6,890 $1,289 18.7%
38222 Biopsy and aspiration of bone marrow sample for diagnosis Facility 2023 17 17 $12,895 $880.43 6.8%
99441 Telephone medical discussion with physician, 5-10 minutes Facility 2023 15 16 $1,950 $382.08 19.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 55 63 $10,444 $2,839 27.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 11 12 $3,023 $760.96 25.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Facility 2022 16 17 $2,015 $429.67 21.3%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 70 85 $13,440 $3,982 29.6%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 40 42 $10,236 $2,801 27.4%
99212 Established patient outpatient visit, total time 10-19 minutes Facility 2021 18 18 $2,014 $429.93 21.3%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Facility 2021 12 17 $1,903 $429.93 22.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 64 90 $13,656 $3,188 23.3%
99212 Established patient office or other outpatient visit, typically 10 minutes Facility 2020 50 62 $6,730 $1,001 14.9%

About Jill Miller, PA-C

Jill Miller, PA-C is a Physician Assistant healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1932370038.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jill Miller, PA-C has received a total of $17,496 in payments from pharmaceutical and medical device companies, with $5,492 received in 2024. These payments were reported across 132 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($9,729).

As a Medicare-enrolled provider, Miller has provided services to 504 Medicare beneficiaries, totaling 610 services with total Medicare billing of $23,508. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Houston, TX
  • Active Since 03/17/2008
  • Last Updated 06/08/2021
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1932370038

Products in Payments

  • VENCLEXTA (Drug) $6,177
  • clonoSEQ (Device) $5,383
  • IMBRUVICA (Drug) $2,010
  • Imbruvica (Drug) $1,122
  • UKONIQ (Drug) $630.00
  • CALQUENCE (Drug) $506.54
  • BRUKINSA (Drug) $382.20
  • REBLOZYL (Biological) $218.43
  • Xospata (Drug) $167.51
  • Lunsumio (Biological) $115.77
  • JAKAFI (Drug) $113.25
  • XOSPATA (Drug) $109.01
  • Cresemba (Drug) $85.53
  • SCEMBLIX (Drug) $83.76
  • VONJO (Drug) $55.13
  • Doptelet (Drug) $26.72
  • BOSULIF (Drug) $23.69
  • JAYPIRCA (Drug) $21.36
  • PROMACTA (Drug) $18.99
  • DOPTELET (Drug) $18.86

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Houston